Skip to main content
Erschienen in: Current Diabetes Reports 4/2011

01.08.2011

Painful Diabetic Neuropathy is More than Pain Alone: Examining the Role of Anxiety and Depression as Mediators and Complicators

verfasst von: Rakesh Jain, Shailesh Jain, Charles L. Raison, Vladimir Maletic

Erschienen in: Current Diabetes Reports | Ausgabe 4/2011

Einloggen, um Zugang zu erhalten

Abstract

A wealth of information exists regarding the plight of patients suffering with diabetic peripheral neuropathic pain (DPNP). Although physical pain is certainly a primary challenge in the management of this condition, disorders associated with emotional pain—especially depression and anxiety—also greatly complicate the clinician’s efforts to attain optimal outcomes for DPNP patients. This article reviews the high rate of comorbidity between DPNP and depression/anxiety with a focus on why this pattern of comorbidity exists and what can be done about it. To accomplish this, the many physiologic similarities between neuropathic pain and depression/anxiety are reviewed as a basis for better understanding how, and why, optimal treatment strategies use behavioral and pharmacologic modalities known to improve both physical pain and symptoms of depression and anxiety. We conclude by highlighting that screening, diagnosing, and optimally treating comorbid depression/anxiety not only improves quality of life, these but also positively impacts DPNP pain.
Literatur
1.
Zurück zum Zitat Daly M. Diabetes and depression–a risky combination. Nurs N Z. 2010;16(2):14–5.PubMed Daly M. Diabetes and depression–a risky combination. Nurs N Z. 2010;16(2):14–5.PubMed
2.
Zurück zum Zitat • Bair MJ et al. Prevalence of pain and association with quality of life, depression and glycaemic control in patients with diabetes. Diabet Med. 2010; 27(5):578–84. This article demonstrates the significant association between diabetes and pain.PubMedCrossRef • Bair MJ et al. Prevalence of pain and association with quality of life, depression and glycaemic control in patients with diabetes. Diabet Med. 2010; 27(5):578–84. This article demonstrates the significant association between diabetes and pain.PubMedCrossRef
3.
Zurück zum Zitat Kessler RC, McGonagle KA, Zhao S, Nelson CB. Lifetime and 12 month prevalence of DSM-III-R psychiatric disorders in the United States. Arch Gen Psychiatry. 1994;51:8–19.PubMed Kessler RC, McGonagle KA, Zhao S, Nelson CB. Lifetime and 12 month prevalence of DSM-III-R psychiatric disorders in the United States. Arch Gen Psychiatry. 1994;51:8–19.PubMed
4.
Zurück zum Zitat Michaud CM, Murray CJ, Bloom BR. Burden of disease - implications for future research. JAMA. 2001;285(5):535–9.PubMedCrossRef Michaud CM, Murray CJ, Bloom BR. Burden of disease - implications for future research. JAMA. 2001;285(5):535–9.PubMedCrossRef
5.
Zurück zum Zitat Vehik K, Dabelea D. The changing epidemiology of type 1 diabetes: why is it going through the roof? Diabetes Metab Res Rev. 2010. Vehik K, Dabelea D. The changing epidemiology of type 1 diabetes: why is it going through the roof? Diabetes Metab Res Rev. 2010.
6.
Zurück zum Zitat Farag YM, Gaballa MR. Diabesity: an overview of a rising epidemic. Nephrol Dial Transplant. 2011;26(1):28–35.PubMedCrossRef Farag YM, Gaballa MR. Diabesity: an overview of a rising epidemic. Nephrol Dial Transplant. 2011;26(1):28–35.PubMedCrossRef
7.
Zurück zum Zitat • Li C et al. Diabetes and anxiety in US adults: findings from the 2006 behavioral risk factor surveillance system. Diabet Med. 2008; 25(7):878–81. This article articulates the issue of anxiety disorders in adults with diabetes.PubMedCrossRef • Li C et al. Diabetes and anxiety in US adults: findings from the 2006 behavioral risk factor surveillance system. Diabet Med. 2008; 25(7):878–81. This article articulates the issue of anxiety disorders in adults with diabetes.PubMedCrossRef
8.
Zurück zum Zitat Collins MM, Corcoran P, Perry IJ. Anxiety and depression symptoms in patients with diabetes. Diabet Med. 2009;26(2):153–61.PubMedCrossRef Collins MM, Corcoran P, Perry IJ. Anxiety and depression symptoms in patients with diabetes. Diabet Med. 2009;26(2):153–61.PubMedCrossRef
9.
Zurück zum Zitat Gore M, Brandenburg N, Dukes E, Hoffman DL, Tai KS, Stacey B. Pain severity in diabetic peripheral neuropathy is associated with patient functioning, symptom levels of anxiety and depression, and sleep. J Pain Symptom Manage. 2005;30(4):374–85.PubMedCrossRef Gore M, Brandenburg N, Dukes E, Hoffman DL, Tai KS, Stacey B. Pain severity in diabetic peripheral neuropathy is associated with patient functioning, symptom levels of anxiety and depression, and sleep. J Pain Symptom Manage. 2005;30(4):374–85.PubMedCrossRef
10.
Zurück zum Zitat de Groot M, Anderson R, Freedland KE, Clouse RE, Lustman PJ. Association of depressive and diabetic complications: a meta-analysis. Psychosom Med. 2001;63(4):619–30.PubMed de Groot M, Anderson R, Freedland KE, Clouse RE, Lustman PJ. Association of depressive and diabetic complications: a meta-analysis. Psychosom Med. 2001;63(4):619–30.PubMed
11.
Zurück zum Zitat Waitzfelder B et al. Correlates of depression among people with diabetes: The Translating Research Into Action for Diabetes (TRIAD) study. Prim Care Diabetes. 2010;4(4):215–22.PubMedCrossRef Waitzfelder B et al. Correlates of depression among people with diabetes: The Translating Research Into Action for Diabetes (TRIAD) study. Prim Care Diabetes. 2010;4(4):215–22.PubMedCrossRef
12.
Zurück zum Zitat Pouwer F et al. Prevalence of comorbid depression is high in out-patients with Type 1 or Type 2 diabetes mellitus. Results from three out-patient clinics in the Netherlands. Diabet Med. 2010;27(2):217–24.PubMedCrossRef Pouwer F et al. Prevalence of comorbid depression is high in out-patients with Type 1 or Type 2 diabetes mellitus. Results from three out-patient clinics in the Netherlands. Diabet Med. 2010;27(2):217–24.PubMedCrossRef
13.
Zurück zum Zitat Yoshida S et al. Neuropathy is associated with depression independently of health-related quality of life in Japanese patients with diabetes. Psychiatry Clin Neurosci. 2009;63(1):65–72.PubMedCrossRef Yoshida S et al. Neuropathy is associated with depression independently of health-related quality of life in Japanese patients with diabetes. Psychiatry Clin Neurosci. 2009;63(1):65–72.PubMedCrossRef
14.
Zurück zum Zitat Sulaiman N, Handam A, Tamim H, Mahmood DA, Young D, The prevalence and coorelates of depression and anxiety in a sampe of diabetic patients in Sharjah, United Arab Emirates. BMC Fam Pract. 2010; 11. Sulaiman N, Handam A, Tamim H, Mahmood DA, Young D, The prevalence and coorelates of depression and anxiety in a sampe of diabetic patients in Sharjah, United Arab Emirates. BMC Fam Pract. 2010; 11.
15.
Zurück zum Zitat Raval A, Dhanaraj E, Bhansali A, Grover S, Tiwari P. Prevalence and determinants of depression in type 2 diabetes patients in a tertiary care centre. Indian J Med Res. 2010;132:195–200.PubMed Raval A, Dhanaraj E, Bhansali A, Grover S, Tiwari P. Prevalence and determinants of depression in type 2 diabetes patients in a tertiary care centre. Indian J Med Res. 2010;132:195–200.PubMed
16.
Zurück zum Zitat Wagner JA, Tennen H, Osborn CY. Lifetime depression and diabetes self-management in women with Type 2 diabetes: a case-control study. Diabet Med. 2010;27(6):713–7.PubMedCrossRef Wagner JA, Tennen H, Osborn CY. Lifetime depression and diabetes self-management in women with Type 2 diabetes: a case-control study. Diabet Med. 2010;27(6):713–7.PubMedCrossRef
17.
Zurück zum Zitat Katon WJ et al. The relationship between changes in depression symptoms and changes in health risk behaviors in patients with diabetes. Int J Geriatr Psychiatry. 2010;25(5):466–75.PubMedCrossRef Katon WJ et al. The relationship between changes in depression symptoms and changes in health risk behaviors in patients with diabetes. Int J Geriatr Psychiatry. 2010;25(5):466–75.PubMedCrossRef
18.
Zurück zum Zitat Rubin RR et al. Cardiovascular disease risk factors, depression symptoms and antidepressant medicine use in the Look AHEAD (Action for Health in Diabetes) clinical trial of weight loss in diabetes. Diabetologia. 2010;53(8):1581–9.PubMedCrossRef Rubin RR et al. Cardiovascular disease risk factors, depression symptoms and antidepressant medicine use in the Look AHEAD (Action for Health in Diabetes) clinical trial of weight loss in diabetes. Diabetologia. 2010;53(8):1581–9.PubMedCrossRef
19.
Zurück zum Zitat Ahola AJ et al. Depression is associated with the metabolic syndrome among patients with type 1 diabetes. Ann Med. 2010;42(7):495–501.PubMedCrossRef Ahola AJ et al. Depression is associated with the metabolic syndrome among patients with type 1 diabetes. Ann Med. 2010;42(7):495–501.PubMedCrossRef
20.
Zurück zum Zitat Raval A et al. Prevalence & determinants of depression in type 2 diabetes patients in a tertiary care centre. Indian J Med Res. 2010;132:195–200.PubMed Raval A et al. Prevalence & determinants of depression in type 2 diabetes patients in a tertiary care centre. Indian J Med Res. 2010;132:195–200.PubMed
21.
Zurück zum Zitat Herzer M, Hood KK. Anxiety symptoms in adolescents with type 1 diabetes: association with blood glucose monitoring and glycemic control. J Pediatr Psychol. 2010;35(4):415–25.PubMedCrossRef Herzer M, Hood KK. Anxiety symptoms in adolescents with type 1 diabetes: association with blood glucose monitoring and glycemic control. J Pediatr Psychol. 2010;35(4):415–25.PubMedCrossRef
22.
Zurück zum Zitat Le TK, Able SL, Lage MJ. Resource use among patients with diabetes, diabetic neuropathy, or diabetes with depression. Cost Eff Resour Alloc. 2006;4:18.PubMedCrossRef Le TK, Able SL, Lage MJ. Resource use among patients with diabetes, diabetic neuropathy, or diabetes with depression. Cost Eff Resour Alloc. 2006;4:18.PubMedCrossRef
23.
Zurück zum Zitat Boulanger L, Zhao Y, Bao Y, Russell MW. A retrospective study on the impact of comorbid depression or anxiety on healthcare resource use and costs among diabetic neuropathy patients. BMC Health serv Res. 2009; 9(111). Boulanger L, Zhao Y, Bao Y, Russell MW. A retrospective study on the impact of comorbid depression or anxiety on healthcare resource use and costs among diabetic neuropathy patients. BMC Health serv Res. 2009; 9(111).
24.
Zurück zum Zitat Lin EH et al. Depression and advanced complications of diabetes: a prospective cohort study. Diabetes Care. 2010;33(2):264–9.PubMedCrossRef Lin EH et al. Depression and advanced complications of diabetes: a prospective cohort study. Diabetes Care. 2010;33(2):264–9.PubMedCrossRef
25.
Zurück zum Zitat Ali S et al. The association between depression and health-related quality of life in people with type 2 diabetes: a systematic literature review. Diabetes Metab Res Rev. 2010;26(2):75–89.PubMedCrossRef Ali S et al. The association between depression and health-related quality of life in people with type 2 diabetes: a systematic literature review. Diabetes Metab Res Rev. 2010;26(2):75–89.PubMedCrossRef
26.
Zurück zum Zitat •• Pouwer F, Kupper N, Adriaanse MC. Does emotional stress cause type 2 diabetes mellitus? A review from the European Depression in Diabetes (EDID) Research Consortium. Discov Med. 2010; 9(45):112–8. This thought-provoking article asks an important question: does stress act as a catalyst for the development of type 2 diabetes (and presumably its complications) in a prospective fashion? PubMed •• Pouwer F, Kupper N, Adriaanse MC. Does emotional stress cause type 2 diabetes mellitus? A review from the European Depression in Diabetes (EDID) Research Consortium. Discov Med. 2010; 9(45):112–8. This thought-provoking article asks an important question: does stress act as a catalyst for the development of type 2 diabetes (and presumably its complications) in a prospective fashion? PubMed
27.
Zurück zum Zitat • Pan A et al. Bidirectional association between depression and type 2 diabetes mellitus in women. Arch Intern Med. 2010; 170(21):1884–91. This article offers a well-reasoned look at the data on the bi-irectional nature of diabetes and depression.PubMedCrossRef • Pan A et al. Bidirectional association between depression and type 2 diabetes mellitus in women. Arch Intern Med. 2010; 170(21):1884–91. This article offers a well-reasoned look at the data on the bi-irectional nature of diabetes and depression.PubMedCrossRef
28.
Zurück zum Zitat Atlantis E et al. Diabetes incidence associated with depression and antidepressants in the Melbourne Longitudinal Studies on Healthy Ageing (MELSHA). Int J Geriatr Psychiatry. 2010;25(7):688–96.PubMedCrossRef Atlantis E et al. Diabetes incidence associated with depression and antidepressants in the Melbourne Longitudinal Studies on Healthy Ageing (MELSHA). Int J Geriatr Psychiatry. 2010;25(7):688–96.PubMedCrossRef
29.
Zurück zum Zitat Nouwen A et al. Type 2 diabetes mellitus as a risk factor for the onset of depression: a systematic review and meta-analysis. Diabetologia. 2010;53(12):2480–6.PubMedCrossRef Nouwen A et al. Type 2 diabetes mellitus as a risk factor for the onset of depression: a systematic review and meta-analysis. Diabetologia. 2010;53(12):2480–6.PubMedCrossRef
30.
Zurück zum Zitat Vinik AI et al. Diabetic neuropathy in older adults. Clin Geriatr Med. 2008;24(3):407–35. v.PubMedCrossRef Vinik AI et al. Diabetic neuropathy in older adults. Clin Geriatr Med. 2008;24(3):407–35. v.PubMedCrossRef
31.
Zurück zum Zitat Costigan M, Scholz J, Woolf CJ. Neuropathic pain: a maladaptive response of the nervous system to damage. Annual Review of Neuroscience. 2009;32(1):1–32.PubMedCrossRef Costigan M, Scholz J, Woolf CJ. Neuropathic pain: a maladaptive response of the nervous system to damage. Annual Review of Neuroscience. 2009;32(1):1–32.PubMedCrossRef
32.
Zurück zum Zitat • Doupis J et al. Microvascular reactivity and inflammatory cytokines in painful and painless peripheral diabetic neuropathy. J Clin Endocrinol Metab. 2009; 94(6):2157–63. This is an excellent review of the issue of inflammatory cytokines in DPNP.PubMedCrossRef • Doupis J et al. Microvascular reactivity and inflammatory cytokines in painful and painless peripheral diabetic neuropathy. J Clin Endocrinol Metab. 2009; 94(6):2157–63. This is an excellent review of the issue of inflammatory cytokines in DPNP.PubMedCrossRef
34.
Zurück zum Zitat Scholz J, Woolf CJ. The neuropathic pain triad: neurons, immune cells and glia. Nat Neurosci. 2007;10(11):1361–8.PubMedCrossRef Scholz J, Woolf CJ. The neuropathic pain triad: neurons, immune cells and glia. Nat Neurosci. 2007;10(11):1361–8.PubMedCrossRef
35.
Zurück zum Zitat • Maletic V, Raison CL. Neurobiology of depression, fibromyalgia and neuropathic pain. Front Biosci. 2009; 14:5291–338. This article offers a comprehensive review of the shared neurobiology of pain and depression.PubMedCrossRef • Maletic V, Raison CL. Neurobiology of depression, fibromyalgia and neuropathic pain. Front Biosci. 2009; 14:5291–338. This article offers a comprehensive review of the shared neurobiology of pain and depression.PubMedCrossRef
36.
Zurück zum Zitat Baron R. Mechanisms of disease: neuropathic pain–a clinical perspective. Nat Clin Pract Neurol. 2006;2(2):95–106.PubMedCrossRef Baron R. Mechanisms of disease: neuropathic pain–a clinical perspective. Nat Clin Pract Neurol. 2006;2(2):95–106.PubMedCrossRef
38.
Zurück zum Zitat Moalem G, Tracey DJ. Immune and inflammatory mechanisms in neuropathic pain. Brain Res Rev. 2006;51(2):240–64.PubMedCrossRef Moalem G, Tracey DJ. Immune and inflammatory mechanisms in neuropathic pain. Brain Res Rev. 2006;51(2):240–64.PubMedCrossRef
39.
Zurück zum Zitat Ji RR et al. Central sensitization and LTP: do pain and memory share similar mechanisms? Trends Neurosci. 2003;26(12):696–705.PubMedCrossRef Ji RR et al. Central sensitization and LTP: do pain and memory share similar mechanisms? Trends Neurosci. 2003;26(12):696–705.PubMedCrossRef
40.
Zurück zum Zitat Ren K, Dubner R. Neuron-glia crosstalk gets serious: role in pain hypersensitivity. Curr Opin Anaesthesiol. 2008;21(5):570–9.PubMedCrossRef Ren K, Dubner R. Neuron-glia crosstalk gets serious: role in pain hypersensitivity. Curr Opin Anaesthesiol. 2008;21(5):570–9.PubMedCrossRef
41.
Zurück zum Zitat Yunus MB. Role of central sensitization in symptoms beyond muscle pain, and the evaluation of a patient with widespread pain. Best Pract Res Clin Rheumatol. 2007;21(3):481–97.PubMedCrossRef Yunus MB. Role of central sensitization in symptoms beyond muscle pain, and the evaluation of a patient with widespread pain. Best Pract Res Clin Rheumatol. 2007;21(3):481–97.PubMedCrossRef
42.
Zurück zum Zitat Woolf CJ, Mannion RJ. Neuropathic pain: aetiology, symptoms, mechanisms, and management. Lancet. 1999;353(9168):1959–64.PubMedCrossRef Woolf CJ, Mannion RJ. Neuropathic pain: aetiology, symptoms, mechanisms, and management. Lancet. 1999;353(9168):1959–64.PubMedCrossRef
43.
Zurück zum Zitat Kendler KS, Thornton LM, Gardner CO. Stressful life events and previous episodes in the etiology of major depression in women: an evaluation of the “kindling” hypothesis. Am J Psychiatry. 2000;157(8):1243–51.PubMedCrossRef Kendler KS, Thornton LM, Gardner CO. Stressful life events and previous episodes in the etiology of major depression in women: an evaluation of the “kindling” hypothesis. Am J Psychiatry. 2000;157(8):1243–51.PubMedCrossRef
44.
Zurück zum Zitat Post RM. Kindling and sensitization as models for affective episode recurrence, cyclicity, and tolerance phenomena. Neurosci Biobehav Rev. 2007;31(6):858–73.PubMedCrossRef Post RM. Kindling and sensitization as models for affective episode recurrence, cyclicity, and tolerance phenomena. Neurosci Biobehav Rev. 2007;31(6):858–73.PubMedCrossRef
45.
Zurück zum Zitat Miller L. Neurosensitization: A model for persistent disability in chronic pain, depression, and posttraumatic stress disorder following injury. NeuroRehabilitation. 2000;14(1):25–32.PubMed Miller L. Neurosensitization: A model for persistent disability in chronic pain, depression, and posttraumatic stress disorder following injury. NeuroRehabilitation. 2000;14(1):25–32.PubMed
46.
Zurück zum Zitat Dadabhoy D et al. Biology and therapy of fibromyalgia. Evidence-based biomarkers for fibromyalgia syndrome. Arthritis Res Ther. 2008;10(4):211.PubMedCrossRef Dadabhoy D et al. Biology and therapy of fibromyalgia. Evidence-based biomarkers for fibromyalgia syndrome. Arthritis Res Ther. 2008;10(4):211.PubMedCrossRef
47.
Zurück zum Zitat Tracey I, Mantyh PW. The cerebral signature for pain perception and its modulation. Neuron. 2007;55(3):377–91.PubMedCrossRef Tracey I, Mantyh PW. The cerebral signature for pain perception and its modulation. Neuron. 2007;55(3):377–91.PubMedCrossRef
48.
Zurück zum Zitat Blackburn-Munro G, Blackburn-Munro RE. Chronic pain, chronic stress and depression: coincidence or consequence? J Neuroendocrinol. 2001;13(12):1009–23.PubMedCrossRef Blackburn-Munro G, Blackburn-Munro RE. Chronic pain, chronic stress and depression: coincidence or consequence? J Neuroendocrinol. 2001;13(12):1009–23.PubMedCrossRef
49.
Zurück zum Zitat Schweinhardt P et al. Investigation into the neural correlates of emotional augmentation of clinical pain. Neuroimage. 2008;40(2):759–66.PubMedCrossRef Schweinhardt P et al. Investigation into the neural correlates of emotional augmentation of clinical pain. Neuroimage. 2008;40(2):759–66.PubMedCrossRef
50.
Zurück zum Zitat Borsook D et al. Neuroimaging revolutionizes therapeutic approaches to chronic pain. Mol Pain. 2007;3:25.PubMedCrossRef Borsook D et al. Neuroimaging revolutionizes therapeutic approaches to chronic pain. Mol Pain. 2007;3:25.PubMedCrossRef
51.
52.
Zurück zum Zitat Apkarian AV et al. Human brain mechanisms of pain perception and regulation in health and disease. Eur J Pain. 2005;9(4):463–84.PubMedCrossRef Apkarian AV et al. Human brain mechanisms of pain perception and regulation in health and disease. Eur J Pain. 2005;9(4):463–84.PubMedCrossRef
53.
Zurück zum Zitat Raison CL, Capuron L, Miller AH. Cytokines sing the blues: inflammation and the pathogenesis of depression. Trends Immunol. 2006;27(1):24–31.PubMedCrossRef Raison CL, Capuron L, Miller AH. Cytokines sing the blues: inflammation and the pathogenesis of depression. Trends Immunol. 2006;27(1):24–31.PubMedCrossRef
54.
55.
Zurück zum Zitat Apkarian AV et al. Chronic back pain is associated with decreased prefrontal and thalamic gray matter density. J Neurosci. 2004;24(46):10410–5.PubMedCrossRef Apkarian AV et al. Chronic back pain is associated with decreased prefrontal and thalamic gray matter density. J Neurosci. 2004;24(46):10410–5.PubMedCrossRef
56.
Zurück zum Zitat Sorensen L et al. Differences in metabolites in pain-processing brain regions in patients with diabetes and painful neuropathy. Diabetes Care. 2008;31(5):980–1.PubMedCrossRef Sorensen L et al. Differences in metabolites in pain-processing brain regions in patients with diabetes and painful neuropathy. Diabetes Care. 2008;31(5):980–1.PubMedCrossRef
57.
Zurück zum Zitat Cauda F et al. Altered resting state in diabetic neuropathic pain. PLoS ONE. 2009;4(2):e4542.PubMedCrossRef Cauda F et al. Altered resting state in diabetic neuropathic pain. PLoS ONE. 2009;4(2):e4542.PubMedCrossRef
58.
Zurück zum Zitat Cauda F et al. Low-frequency BOLD fluctuations demonstrate altered thalamocortical connectivity in diabetic neuropathic pain. BMC Neurosci. 2009;10:138.PubMedCrossRef Cauda F et al. Low-frequency BOLD fluctuations demonstrate altered thalamocortical connectivity in diabetic neuropathic pain. BMC Neurosci. 2009;10:138.PubMedCrossRef
59.
Zurück zum Zitat Frodl T et al. Effect of hippocampal and amygdala volumes on clinical outcomes in major depression: a 3-year prospective magnetic resonance imaging study. J Psychiatry Neurosci. 2008;33(5):423–30.PubMed Frodl T et al. Effect of hippocampal and amygdala volumes on clinical outcomes in major depression: a 3-year prospective magnetic resonance imaging study. J Psychiatry Neurosci. 2008;33(5):423–30.PubMed
60.
Zurück zum Zitat Matthews SC et al. Decreased functional coupling of the amygdala and supragenual cingulate is related to increased depression in unmedicated individuals with current major depressive disorder. J Affect Disord. 2008;111(1):13–20.PubMedCrossRef Matthews SC et al. Decreased functional coupling of the amygdala and supragenual cingulate is related to increased depression in unmedicated individuals with current major depressive disorder. J Affect Disord. 2008;111(1):13–20.PubMedCrossRef
61.
Zurück zum Zitat Baliki MN et al. Chronic pain and the emotional brain: specific brain activity associated with spontaneous fluctuations of intensity of chronic back pain. J Neurosci. 2006;26(47):12165–73.PubMedCrossRef Baliki MN et al. Chronic pain and the emotional brain: specific brain activity associated with spontaneous fluctuations of intensity of chronic back pain. J Neurosci. 2006;26(47):12165–73.PubMedCrossRef
62.
Zurück zum Zitat Goncalves L et al. Neuropathic pain is associated with depressive behaviour and induces neuroplasticity in the amygdala of the rat. Exp Neurol. 2008;213(1):48–56.PubMedCrossRef Goncalves L et al. Neuropathic pain is associated with depressive behaviour and induces neuroplasticity in the amygdala of the rat. Exp Neurol. 2008;213(1):48–56.PubMedCrossRef
63.
Zurück zum Zitat Tsigos C, Chrousos GP. Hypothalamic-pituitary-adrenal axis, neuroendocrine factors and stress. J Psychosom Res. 2002;53(4):865–71.PubMedCrossRef Tsigos C, Chrousos GP. Hypothalamic-pituitary-adrenal axis, neuroendocrine factors and stress. J Psychosom Res. 2002;53(4):865–71.PubMedCrossRef
64.
Zurück zum Zitat Strouse TB. The relationship between cytokines and pain/depression: a review and current status. Curr Pain Headache Rep. 2007;11(2):98–103.PubMedCrossRef Strouse TB. The relationship between cytokines and pain/depression: a review and current status. Curr Pain Headache Rep. 2007;11(2):98–103.PubMedCrossRef
65.
Zurück zum Zitat Rajkowska G, Miguel-Hidalgo JJ. Gliogenesis and glial pathology in depression. CNS Neurol Disord Drug Targets. 2007;6(3):219–33.PubMedCrossRef Rajkowska G, Miguel-Hidalgo JJ. Gliogenesis and glial pathology in depression. CNS Neurol Disord Drug Targets. 2007;6(3):219–33.PubMedCrossRef
66.
Zurück zum Zitat Pav M et al. Neurobiological aspects of depressive disorder and antidepressant treatment: role of glia. Physiol Res. 2008;57(2):151–64.PubMed Pav M et al. Neurobiological aspects of depressive disorder and antidepressant treatment: role of glia. Physiol Res. 2008;57(2):151–64.PubMed
67.
Zurück zum Zitat McNally L, Bhagwagar Z, Hannestad J. Inflammation, glutamate, and glia in depression: a literature review. CNS Spectr. 2008;13(6):501–10.PubMed McNally L, Bhagwagar Z, Hannestad J. Inflammation, glutamate, and glia in depression: a literature review. CNS Spectr. 2008;13(6):501–10.PubMed
68.
Zurück zum Zitat Tsuda M, Inoue K, Salter MW. Neuropathic pain and spinal microglia: a big problem from molecules in “small” glia. Trends Neurosci. 2005;28(2):101–7.PubMedCrossRef Tsuda M, Inoue K, Salter MW. Neuropathic pain and spinal microglia: a big problem from molecules in “small” glia. Trends Neurosci. 2005;28(2):101–7.PubMedCrossRef
69.
Zurück zum Zitat Zieglgansberger W, Berthele A, Tolle TR. Understanding neuropathic pain. CNS Spectr. 2005;10(4):298–308.PubMed Zieglgansberger W, Berthele A, Tolle TR. Understanding neuropathic pain. CNS Spectr. 2005;10(4):298–308.PubMed
70.
Zurück zum Zitat Chapman CR, Tuckett RP, Song CW. Pain and stress in a systems perspective: reciprocal neural, endocrine, and immune interactions. J Pain. 2008;9(2):122–45.PubMedCrossRef Chapman CR, Tuckett RP, Song CW. Pain and stress in a systems perspective: reciprocal neural, endocrine, and immune interactions. J Pain. 2008;9(2):122–45.PubMedCrossRef
71.
Zurück zum Zitat Wieseler-Frank J, Maier SF, Watkins LR. Immune-to-brain communication dynamically modulates pain: physiological and pathological consequences. Brain Behav Immun. 2005;19(2):104–11.PubMedCrossRef Wieseler-Frank J, Maier SF, Watkins LR. Immune-to-brain communication dynamically modulates pain: physiological and pathological consequences. Brain Behav Immun. 2005;19(2):104–11.PubMedCrossRef
72.
Zurück zum Zitat Acee AM. Detecting and managing depression in type II diabetes: PHQ-9 is the answer! Medsurg Nurs. 2010;19(1):32–8.PubMed Acee AM. Detecting and managing depression in type II diabetes: PHQ-9 is the answer! Medsurg Nurs. 2010;19(1):32–8.PubMed
73.
Zurück zum Zitat van Steenbergen-Weijenburg KM et al. Validation of the PHQ-9 as a screening instrument for depression in diabetes patients in specialized outpatient clinics. BMC Health Serv Res. 2010;10:235.PubMedCrossRef van Steenbergen-Weijenburg KM et al. Validation of the PHQ-9 as a screening instrument for depression in diabetes patients in specialized outpatient clinics. BMC Health Serv Res. 2010;10:235.PubMedCrossRef
74.
Zurück zum Zitat Brennan C et al. The hospital anxiety and depression scale: a diagnostic meta-analysis of case-finding ability. J Psychosom Res. 2010;69(4):371–8.PubMedCrossRef Brennan C et al. The hospital anxiety and depression scale: a diagnostic meta-analysis of case-finding ability. J Psychosom Res. 2010;69(4):371–8.PubMedCrossRef
75.
Zurück zum Zitat Lloyd CE, Dyer PH, Barnett AH. Prevalence of symptoms of depression and anxiety in a diabetes clinic population. Diabet Med. 2000;17(3):198–202.PubMedCrossRef Lloyd CE, Dyer PH, Barnett AH. Prevalence of symptoms of depression and anxiety in a diabetes clinic population. Diabet Med. 2000;17(3):198–202.PubMedCrossRef
76.
Zurück zum Zitat Spitzer RL et al. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med. 2006;166(10):1092–7.PubMedCrossRef Spitzer RL et al. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med. 2006;166(10):1092–7.PubMedCrossRef
77.
Zurück zum Zitat Lowe B et al. Validation and standardization of the Generalized Anxiety Disorder Screener (GAD-7) in the general population. Med Care. 2008;46(3):266–74.PubMedCrossRef Lowe B et al. Validation and standardization of the Generalized Anxiety Disorder Screener (GAD-7) in the general population. Med Care. 2008;46(3):266–74.PubMedCrossRef
78.
Zurück zum Zitat • Reddy P et al. Identification of depression in diabetes: the efficacy of PHQ-9 and HADS-D. Br J Gen Pract. 2010; 60(575):239–45. This article offers a fair balanced review of the benefits and potential pitfalls of using PHQ-9 and HADS-D in DPNP patients.CrossRef • Reddy P et al. Identification of depression in diabetes: the efficacy of PHQ-9 and HADS-D. Br J Gen Pract. 2010; 60(575):239–45. This article offers a fair balanced review of the benefits and potential pitfalls of using PHQ-9 and HADS-D in DPNP patients.CrossRef
79.
Zurück zum Zitat Gonzalez JS, Esbitt SA. Depression and treatment nonadherence in type 2 diabetes: assessment issues and an integrative treatment approach. Epidemiol Psichiatr Soc. 2010;19(2):110–5.PubMed Gonzalez JS, Esbitt SA. Depression and treatment nonadherence in type 2 diabetes: assessment issues and an integrative treatment approach. Epidemiol Psichiatr Soc. 2010;19(2):110–5.PubMed
80.
Zurück zum Zitat Fortmann AL et al. Support for disease management, depression, self-care, and clinical indicators among Hispanics with type 2 diabetes in San Diego County, United States of America. Rev Panam Salud Publica. 2010;28(3):230–4.PubMedCrossRef Fortmann AL et al. Support for disease management, depression, self-care, and clinical indicators among Hispanics with type 2 diabetes in San Diego County, United States of America. Rev Panam Salud Publica. 2010;28(3):230–4.PubMedCrossRef
81.
Zurück zum Zitat Echeverry D et al. Effect of pharmacological treatment of depression on A1C and quality of life in low-income Hispanics and African Americans with diabetes: a randomized, double-blind, placebo-controlled trial. Diabetes Care. 2009;32(12):2156–60.PubMedCrossRef Echeverry D et al. Effect of pharmacological treatment of depression on A1C and quality of life in low-income Hispanics and African Americans with diabetes: a randomized, double-blind, placebo-controlled trial. Diabetes Care. 2009;32(12):2156–60.PubMedCrossRef
82.
Zurück zum Zitat Bogner HR, de Vries HF. Integrating type 2 diabetes mellitus and depression treatment among African Americans: a randomized controlled pilot trial. Diabetes Educ. 2010;36(2):284–92.PubMedCrossRef Bogner HR, de Vries HF. Integrating type 2 diabetes mellitus and depression treatment among African Americans: a randomized controlled pilot trial. Diabetes Educ. 2010;36(2):284–92.PubMedCrossRef
83.
Zurück zum Zitat Ell K et al. Collaborative care management of major depression among low-income, predominantly Hispanic subjects with diabetes: a randomized controlled trial. Diabetes Care. 2010;33(4):706–13.PubMedCrossRef Ell K et al. Collaborative care management of major depression among low-income, predominantly Hispanic subjects with diabetes: a randomized controlled trial. Diabetes Care. 2010;33(4):706–13.PubMedCrossRef
84.
Zurück zum Zitat • Ismail K et al. A randomised controlled trial of cognitive behaviour therapy and motivational interviewing for people with Type 1 diabetes mellitus with persistent sub-optimal glycaemic control: a Diabetes and Psychological Therapies (ADaPT) study. Health Technol Assess. 2010; 14(22):1–101, iii-iv. This article demosntates the importnace of nonpharmacologic interventions in diabetes. PubMed • Ismail K et al. A randomised controlled trial of cognitive behaviour therapy and motivational interviewing for people with Type 1 diabetes mellitus with persistent sub-optimal glycaemic control: a Diabetes and Psychological Therapies (ADaPT) study. Health Technol Assess. 2010; 14(22):1–101, iii-iv. This article demosntates the importnace of nonpharmacologic interventions in diabetes. PubMed
85.
Zurück zum Zitat van Bastelaar K et al. Development and reach of a web-based cognitive behavioural therapy programme to reduce symptoms of depression and diabetes-specific distress. Patient Educ Couns. 2010. van Bastelaar K et al. Development and reach of a web-based cognitive behavioural therapy programme to reduce symptoms of depression and diabetes-specific distress. Patient Educ Couns. 2010.
86.
Zurück zum Zitat Kuritzky L. Managing diabetic peripheral neuropathic pain in primary care. J Fam Pract. 2010;59(5 Suppl):S15–22.PubMed Kuritzky L. Managing diabetic peripheral neuropathic pain in primary care. J Fam Pract. 2010;59(5 Suppl):S15–22.PubMed
87.
Zurück zum Zitat Tesfaye S. Advances in the management of diabetic peripheral neuropathy. Curr Opin Support Palliat Care. 2009;3(2):136–43.PubMedCrossRef Tesfaye S. Advances in the management of diabetic peripheral neuropathy. Curr Opin Support Palliat Care. 2009;3(2):136–43.PubMedCrossRef
89.
Zurück zum Zitat Smink BE, Egberts ACG, Lusthof KJ. The relationship between benzodiazepine use and traffic accident: a systematic litreature review. CNS Drugs. 2010;24(8):639–53.PubMedCrossRef Smink BE, Egberts ACG, Lusthof KJ. The relationship between benzodiazepine use and traffic accident: a systematic litreature review. CNS Drugs. 2010;24(8):639–53.PubMedCrossRef
90.
Zurück zum Zitat Uzun S et al. Side effects of treatment with benzodiazepines. Psychiatr Danub. 2010;22(1):90–3.PubMed Uzun S et al. Side effects of treatment with benzodiazepines. Psychiatr Danub. 2010;22(1):90–3.PubMed
91.
Zurück zum Zitat Skljarevski V et al. Evaluating the maintenance of effect of duloxetine in patients with diabetic peripheral neuropathic pain. Diabetes Metab Res Rev. 2009;25(7):623–31.PubMedCrossRef Skljarevski V et al. Evaluating the maintenance of effect of duloxetine in patients with diabetic peripheral neuropathic pain. Diabetes Metab Res Rev. 2009;25(7):623–31.PubMedCrossRef
92.
Zurück zum Zitat Rynn M et al. Efficacy and safety of duloxetine in the treatment of generalized anxiety disorder: a flexible-dose, progressive-titration, placebo-controlled trial. Depress Anxiety. 2008;25(3):182–9.PubMedCrossRef Rynn M et al. Efficacy and safety of duloxetine in the treatment of generalized anxiety disorder: a flexible-dose, progressive-titration, placebo-controlled trial. Depress Anxiety. 2008;25(3):182–9.PubMedCrossRef
93.
Zurück zum Zitat Kornstein SG et al. A randomized, double-blind study of increasing or maintaining duloxetine dose in patients without remission of major depressive disorder after initial duloxetine therapy. J Clin Psychiatry. 2008;69(9):1383–92.PubMedCrossRef Kornstein SG et al. A randomized, double-blind study of increasing or maintaining duloxetine dose in patients without remission of major depressive disorder after initial duloxetine therapy. J Clin Psychiatry. 2008;69(9):1383–92.PubMedCrossRef
94.
Zurück zum Zitat Abrahamian H et al. Diabetes mellitus and co-morbid depression: treatment with milnacipran results in significant improvement of both diseases (results from the Austrian MDDM study group). Neuropsychiatr Dis Treat. 2009;5:261–6.PubMedCrossRef Abrahamian H et al. Diabetes mellitus and co-morbid depression: treatment with milnacipran results in significant improvement of both diseases (results from the Austrian MDDM study group). Neuropsychiatr Dis Treat. 2009;5:261–6.PubMedCrossRef
95.
Zurück zum Zitat Lieberman DZ, Massey SH. Desvenlafaxine in major depressive disorder: an evidence-based review of its place in therapy. Core Evid. 2010;4:67–82.PubMed Lieberman DZ, Massey SH. Desvenlafaxine in major depressive disorder: an evidence-based review of its place in therapy. Core Evid. 2010;4:67–82.PubMed
96.
Zurück zum Zitat Pae CU et al. Milnacipran: beyond a role of antidepressant. Clin Neuropharmacol. 2009;32(6):355–63.PubMedCrossRef Pae CU et al. Milnacipran: beyond a role of antidepressant. Clin Neuropharmacol. 2009;32(6):355–63.PubMedCrossRef
97.
Zurück zum Zitat Golden RN, Nicholas L. Antidepressant efficacy of venlafaxine. Depress Anxiety. 2000;12 Suppl 1:45–9.PubMedCrossRef Golden RN, Nicholas L. Antidepressant efficacy of venlafaxine. Depress Anxiety. 2000;12 Suppl 1:45–9.PubMedCrossRef
98.
Zurück zum Zitat Di Guilmi MN et al. Pregabalin modulation of neurotransmitter release is mediated by change in intrinsic activation/inactivation properties of CaV2.1 calcium channels. J Pharmacol Exp Ther. 2010. Di Guilmi MN et al. Pregabalin modulation of neurotransmitter release is mediated by change in intrinsic activation/inactivation properties of CaV2.1 calcium channels. J Pharmacol Exp Ther. 2010.
99.
Zurück zum Zitat Satosh J, Yagihashi S, Baba M, Suzuki M. Efficacy and safety of pregabalin for treating neuropathic pain associated with diabetic peripheral neuropathy: a 14 week, randomized, double blind, placebo-controlled trial. Diabet Med. 2011;28(1):109–16.CrossRef Satosh J, Yagihashi S, Baba M, Suzuki M. Efficacy and safety of pregabalin for treating neuropathic pain associated with diabetic peripheral neuropathy: a 14 week, randomized, double blind, placebo-controlled trial. Diabet Med. 2011;28(1):109–16.CrossRef
100.
Zurück zum Zitat Montgomery SA, Herman BK, Schweizer E. The efficacy of pregabalin and benzodiazepines in generalized anxiety disorder presenting with high levels of insomnia. Int Clin Psychopharmacology. 2009;24(4):214–22.CrossRef Montgomery SA, Herman BK, Schweizer E. The efficacy of pregabalin and benzodiazepines in generalized anxiety disorder presenting with high levels of insomnia. Int Clin Psychopharmacology. 2009;24(4):214–22.CrossRef
101.
Zurück zum Zitat Bryan C et al. The impact of diabetes on depression treatment outcomes. Gen Hosp Psychiatry. 2010;32(1):33–41.PubMedCrossRef Bryan C et al. The impact of diabetes on depression treatment outcomes. Gen Hosp Psychiatry. 2010;32(1):33–41.PubMedCrossRef
102.
Zurück zum Zitat Osborn CY, Kozak C, Wagner J. Theory in practice: helping providers address depression in diabetes care. J Contin Educ Health Prof. 2010;30(3):172–9.PubMedCrossRef Osborn CY, Kozak C, Wagner J. Theory in practice: helping providers address depression in diabetes care. J Contin Educ Health Prof. 2010;30(3):172–9.PubMedCrossRef
103.
Zurück zum Zitat Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). Arlington, VA: APA Press; 2000. Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). Arlington, VA: APA Press; 2000.
Metadaten
Titel
Painful Diabetic Neuropathy is More than Pain Alone: Examining the Role of Anxiety and Depression as Mediators and Complicators
verfasst von
Rakesh Jain
Shailesh Jain
Charles L. Raison
Vladimir Maletic
Publikationsdatum
01.08.2011
Verlag
Current Science Inc.
Erschienen in
Current Diabetes Reports / Ausgabe 4/2011
Print ISSN: 1534-4827
Elektronische ISSN: 1539-0829
DOI
https://doi.org/10.1007/s11892-011-0202-2

Weitere Artikel der Ausgabe 4/2011

Current Diabetes Reports 4/2011 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.